THE FIRST NEW MONOTHERAPY THERAPEUTIC PBC STUDY IN A DECADE? AN INTERNATIONAL STUDY EVALUATING THE FARNESOID X RECEPTOR AGONIST OBETICHOLIC ACID IN PBC by Kowdley, K, Luketic, V, Jones, D, Chapman, R, Burroughs, A, Hirschfield, G, Poupon, R, Schramm, C, Vincent, C, Rust, C, Pares, A, Mason, A, Castelloe, E, Sciacca, C, Boehm, O, Pruzanski, M, Shapiro, D

AN INTERNATIONAL STUDY EVALUATING THE FARNESOID X RECEPTOR AGONIST OBETICHOLIC ACID AS MONOTHERAPY IN PBC by Kowdley, K, Jones, D, Luketic, V, Chapman, R, Burroughs, A, Hirschfield, G, Poupon, R, Schramm, C, Vincent, C, Rust, C, Pares, A, Mason, A, Sciacca, C, Beecher-Jones, T, Bohm, O, Castelloe, E, Pruzanski, M, Shapiro, D, Grp, O

A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis by Kowdley, K, Luketic, V, Chapman, R, Hirschfield, G, Poupon, R, Schramm, C, Vincent, C, Rust, C, Parés, A, Mason, A, Marschall, H, Shapiro, D, Adorini, L, Sciacca, C, Beecher-Jones, T, Böhm, O, Pencek, R, Jones, D, Obeticholic Acid Pbc Monotherapy Study Group